EMBEDDED RESEARCH
We use research as an instrument of justice.
Muso conducts rigorous research because our patients deserve the truth. Just as patients deserve medications that have been proven to work, so do communities deserve health systems that have proven efficacy. Good intentions are not enough. Our patients deserve health care systems that work, that are evidence-based. That is why we test everything we do.
Conventional health care systems measure their impact based on how they treat patients who walk through the door. For Muso, health systems should care as much about the patients who never make it to the door of the health center. That is why we measure our success based on changes in population-level health outcomes. Our proactive model has been developed with over more than a decade of research in collaboration with our government and academic partners.
560
COMMUNITY HEALTH WORKERS
(CHWs)
549,000
POPULATION SERVED SINCE 2008
4,971
FAMILY PLANNING METHODS DELIVERED BY CHWs IN Q3 2023
16,398,327
HOME VISITS
95.15%
OF CHILDREN < 5 REACHED
WITHIN 24H BY CHWs
1,631,032
FEE-FREE CLINIC VISITS
REAL-TIME LEARNING
We analyze the services Community Health Workers, doctors, and other providers offer daily as they care for patients. These systems track the outputs of our health systems to help us define the quality, quantity, and speed of care delivered.
​
Using this real-time learning, our Monitoring & Evaluation Program and Learning & Innovation teams are able to pinpoint and resolve challenges in care delivery through health worker training and program enhancements.
POPULATION-LEVEL IMPACT
Muso conducts research to find global solutions to global injustices—to identify what strategies work, what strategies do harm, and what strategies can accelerate the global effort for universal health care and child survival.
By conducting scientific studies with academic partners, we measure our outcomes at a population level, to assess how the health of entire communities changes. We also accompany our largest Technical Assistance partner, the government of Mali, in evaluating programs at scale. Our studies help us learn and improve our programming, and provide us evidence to better serve the communities where we work and to share our learnings with partners around the world.
RESEARCH STUDIES
At Muso, we conduct rigorous research studies to measure the impact of our programs and to inform the technical assistance we provide to our government partners. This research is also designed to answer generalizable questions relevant to the broader international health community.
ONGOING STUDIES
MOBILE RAPID DIAGNOSTIC
TESTING (mRDT)
Developing and testing a set of mobile health tools for CHWs to improve mobile Rapid Diagnostic Testing (mRDT) quality, coverage, and equity as part of integrated primary health care delivery.
DEDICATED CHW SUPERVISION AT SCALE
Muso's 360° Supervision model has been adopted nationally by Mali's government. This study will evaluate the effects of dedicated supervision for the country's Community Health Workers.
ProCCM TRIAL MALARIA PREVALENCE EVALUATION
This endline evaluation, embedded within the ProCCM Trial, will assess the impact of proactive case detection by CHWs on malaria prevalence, transmission, and antimalarial resistance in children under 5 and pregnant women.
ProCCM TRIAL PROCESS
EVALUATION
A mixed-method process evaluation will be conducted as a part of the trial to assess implementation fidelity, mechanisms of action, and context of the intervention.
ProCCM TRIAL COST-
EFFECTIVENESS ANALISIS
This embedded analysis will evaluate the relative cost-effectiveness of the ProCCM model with respect to the current standard iCCM model for CHWs.
FAMILY PLANNING STUDY
A new study assesses whether communities receiving proactive care see increased access to family planning.
